About Ann Lee-Karlon
Form D filings for EpiBiologics in 2024 list Ann Lee-Karlon as CEO and director.
Ann Lee-Karlon first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ann Lee-Karlon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ann Lee-Karlon works with at each company, as listed on that company's latest Form D.
EpiBiologics, Inc. · Form D/A, Apr 25, 2024
JC
Jason Coloma
Director
SB
Samuel Bjork
Director
Alexandra Cantley
Director
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director
JW
James Wells
Director